Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures.

Nakamura KJ, Heath L, Sobrera ER, Wilkinson TA, Semrau K, Kankasa C, Tobin NH, Webb NE, Lee B, Thea DM, Kuhn L, Mullins JI, Aldrovandi GM.

Retrovirology. 2017 Jan 26;14(1):6. doi: 10.1186/s12977-017-0331-z.

2.

Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.

Swanstrom AE, Haggarty B, Jordan AP, Romano J, Leslie GJ, Aye PP, Marx PA, Lackner AA, Del Prete GQ, Robinson JE, Betts MR, Montefiori DC, LaBranche CC, Hoxie JA.

J Virol. 2016 Apr 29;90(10):4966-80. doi: 10.1128/JVI.02851-15. Print 2016 May 15.

3.

Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages.

Hollenbaugh JA, Montero C, Schinazi RF, Munger J, Kim B.

Virology. 2016 Apr;491:106-14. doi: 10.1016/j.virol.2016.01.023. Epub 2016 Feb 16.

4.

Soluble Envelope Glycoprotein Trimers from a CD4-Independent HIV-1 Elicit Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Guinea Pigs.

Murray MK, Teran VA, Chapleau JP, Wang B, Kim SH, LaBranche CC, Richard J, Montefiori DC, Finzi A, Yuan W.

J Virol. 2015 Oct;89(20):10707-11. doi: 10.1128/JVI.01642-15. Epub 2015 Aug 5.

5.

Acquisition of CD4-dependence by CD4-independent SIV passaged in human peripheral blood mononuclear cells.

Iyengar S, Schwartz DH.

Retrovirology. 2012 Jul 25;9:61. doi: 10.1186/1742-4690-9-61.

6.

HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.

Schader SM, Colby-Germinario SP, Quashie PK, Oliveira M, Ibanescu RI, Moisi D, Mespléde T, Wainberg MA.

Antimicrob Agents Chemother. 2012 Aug;56(8):4257-67. doi: 10.1128/AAC.00639-12. Epub 2012 May 21.

7.

MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.

Grupping K, Selhorst P, Michiels J, Vereecken K, Heyndrickx L, Kessler P, Vanham G, Martin L, Ariën KK.

Retrovirology. 2012 May 2;9:36. doi: 10.1186/1742-4690-9-36.

8.

A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop.

Ringe R, Sharma D, Zolla-Pazner S, Phogat S, Risbud A, Thakar M, Paranjape R, Bhattacharya J.

Virology. 2011 Sep 30;418(2):123-32. doi: 10.1016/j.virol.2011.07.015. Epub 2011 Aug 17.

9.

Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity.

Haim H, Strack B, Kassa A, Madani N, Wang L, Courter JR, Princiotto A, McGee K, Pacheco B, Seaman MS, Smith AB 3rd, Sodroski J.

PLoS Pathog. 2011 Jun;7(6):e1002101. doi: 10.1371/journal.ppat.1002101. Epub 2011 Jun 23.

10.

PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons.

Zou S, El-Hage N, Podhaizer EM, Knapp PE, Hauser KF.

J Neurovirol. 2011 Feb;17(1):41-9. doi: 10.1007/s13365-010-0016-z. Epub 2011 Jan 14.

11.

Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells.

Lyle C, McCormick F.

Virol J. 2010 Jul 8;7:148. doi: 10.1186/1743-422X-7-148.

12.

A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.

Willett BJ, McMonagle EL, Logan N, Samman A, Hosie MJ.

Retrovirology. 2008 Aug 22;5:77. doi: 10.1186/1742-4690-5-77.

13.

Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching.

Pastore C, Nedellec R, Ramos A, Hartley O, Miamidian JL, Reeves JD, Mosier DE.

J Virol. 2007 Aug;81(15):8165-79. Epub 2007 May 16.

15.
16.

Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.

Cheng HH, Anderson MM, Hankenson FC, Johnston L, Kotwaliwale CV, Overbaugh J.

J Virol. 2006 Feb;80(4):1619-28. Erratum in: J Virol. 2006 Dec;80(24):12431.

17.

Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains.

Steckbeck JD, Orlov I, Chow A, Grieser H, Miller K, Bruno J, Robinson JE, Montelaro RC, Cole KS.

J Virol. 2005 Oct;79(19):12311-20.

18.
19.

Supplemental Content

Support Center